Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes
Abstract
1. Introduction
2. Results
3. Discussion
4. Materials and Methods
Statistical Analysis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Casper, D.S.; Fleischman, A.N.; Papas, P.V.; Grossman, J.; Scuderi, G.R.; Lonner, J.H. Unicompartmental Knee Arthroplasty Provides Significantly Greater Improvement in Function than Total Knee Arthroplasty Despite Equivalent Satisfaction for Isolated Medial Compartment Osteoarthritis. J. Arthroplast. 2019, 34, 1611–1616. [Google Scholar] [CrossRef] [PubMed]
- Liu, L.; Li, J.; Wang, Y.; Li, X.; Han, P.; Li, X. Cemented versus cementless Oxford unicompartmental knee arthroplasty for the treatment of medial knee osteoarthritis: An updated systematic review and meta-analysis. Arch. Orthop. Trauma Surg. 2024, 144, 4391–4403. [Google Scholar] [CrossRef] [PubMed]
- Sutton, P.M.; Murray, J.S. The National Joint Registry 22 years on: What have we learned about knee replacements? Orthop. Trauma 2025, 39, 74–80. [Google Scholar] [CrossRef]
- Ryan, S.P.; Stambough, J.B.; Huddleston, J.I.; Levine, B.R. Highlights of the 2023 American Joint Replacement Registry Annual Report. Arthroplast. Today 2024, 26, 101325. [Google Scholar] [CrossRef]
- Johal, S.; Nakano, N.; Baxter, M.; Hujazi, I.; Pandit, H.; Khanduja, V. Unicompartmental Knee Arthroplasty: The Past, Current Controversies, and Future Perspectives. J. Knee Surg. 2018, 31, 992–998. [Google Scholar] [CrossRef]
- Zanirato, A.; Cavagnaro, L.; Chiarlone, F.; Quarto, E.; Formica, M. Periprosthetic joint infection in unicompartmental knee arthroplasty: Treatment options and outcomes. What is the current evidence in literature? Arch. Orthop. Trauma Surg. 2023, 143, 1031–1039. [Google Scholar] [CrossRef]
- Tay, M.L.; McGlashan, S.R.; Monk, A.P.; Young, S.W. Revision indications for medial unicompartmental knee arthroplasty: A systematic review. Arch. Orthop. Trauma Surg. 2022, 142, 301–314. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez, H.C.; Mekkawy, K.L.; Watkins, A.; Roche, M.W.; Burke, W.V.; Gosthe, R.G. Risk of Periprosthetic Joint Infection After Intra-Articular Corticosteroid Injection Following Unicompartmental Knee Arthroplasty. J. Arthroplast. 2023, 38, 815–819. [Google Scholar] [CrossRef]
- Lee, C.S.; Su, E.P.; Cross, M.B.; Carli, A.V.; Landy, D.C.; Chalmers, B.P. Unicompartmental Knee Arthroplasty Is Associated with a Lower Rate of Periprosthetic Joint Infection Compared to Total Knee Arthroplasty. Arthroplast. Today 2021, 10, 117–122. [Google Scholar] [CrossRef]
- Longo, U.G.; De Salvatore, S.; Bandini, B.; Lalli, A.; Barillà, B.; Budhiparama, N.C.; Lustig, S. Debridement, antibiotics, and implant retention (DAIR) for the early prosthetic joint infection of total knee and hip arthroplasties: A systematic review. J. ISAKOS 2024, 9, 62–70. [Google Scholar] [CrossRef]
- Weinstein, E.J.; Stephens-Shields, A.J.; Newcomb, C.W.; Silibovsky, R.; Nelson, C.L.; O’Donnell, J.A.; Glaser, L.J.; Hsieh, E.; Hanberg, J.S.; Tate, J.P.; et al. Incidence, Microbiological Studies, and Factors Associated with Prosthetic Joint Infection After Total Knee Arthroplasty. JAMA Netw. Open 2023, 6, e2340457. [Google Scholar] [CrossRef] [PubMed]
- McCormick, K.L.; Xu, W.; Cozzarelli, N.F.; Crawford, D.; Wilson, E.J.; Berend, K.R.; Fricka, K.B.; Lonner, J.H.; Geller, J.A. Debridement, Antibiotics, and Implant Retention in Unicompartmental Knee Arthroplasty Infection. J. Arthroplast. 2024, 39, S285–S289. [Google Scholar] [CrossRef]
- Asadollahi, S.; Hamilton, T.W.; Sabah, S.A.; Scarborough, M.; Price, A.J.; Gibbons, C.L.M.H.; Murray, D.W.; Alvand, A. The outcomes of acute periprosthetic joint infection following unicompartmental knee replacement managed with early debridement, Antibiotics, and implant retention. Knee 2024, 47, 13–20. [Google Scholar] [CrossRef] [PubMed]
- Fehring, T.K.; Fehring, K.A.; Hewlett, A.; Higuera, C.A.; Otero, J.E.; Tande, A.J. What’s New in Musculoskeletal Infection. JBJS 2020, 102, 1222–1229. [Google Scholar] [CrossRef] [PubMed]
- Petis, S.M.; Perry, K.I.; Mabry, T.M.; Hanssen, A.D.; Berry, D.J.; Abdel, M.P. Two-Stage Exchange Protocol for Periprosthetic Joint Infection Following Total Knee Arthroplasty in 245 Knees without Prior Treatment for Infection. JBJS 2019, 101, 239–249. [Google Scholar] [CrossRef]
- Hernandez, N.M.; Petis, S.M.; Hanssen, A.D.; Sierra, R.J.; Abdel, M.P.; Pagnano, M.W. Infection After Unicompartmental Knee Arthroplasty: A High Risk of Subsequent Complications. Clin. Orthop. Relat. Res. 2019, 477, 70–77. [Google Scholar] [CrossRef] [PubMed]
- Koch, K.A.; Weishorn, J.; Freytag, J.; Frey, P.E.; Hariri, M.; Merle, C.; Walker, T. Long-term outcome of periprosthetic joint infection following unicompartmental knee arthroplasty: A single-centre case series. J. Exp. Orthop. 2025, 12, e70230. [Google Scholar] [CrossRef]
- Qasim, S.N.; Swann, A.; Ashford, R. The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement—A literature review. SICOT J. 2017, 3, 2. [Google Scholar] [CrossRef]
- Marculescu, C.E.; Cantey, J.R. Polymicrobial prosthetic joint infections: Risk factors and outcome. Clin. Orthop. Relat. Res. 2008, 466, 1397–1404. [Google Scholar] [CrossRef]
- Cavagnaro, L.; Chiarlone, F.; Mosconi, L.; Zanirato, A.; Formica, M.; Burastero, G. Two-stage revision for periprosthetic joint infection in unicompartmental knee arthroplasty: Clinical and radiological results. Arch. Orthop. Trauma Surg. 2022, 142, 2031–2038. [Google Scholar] [CrossRef]
- Tsai, S.-W.; Mu, W.; Parvizi, J. Culture-negative periprosthetic joint infections: Do we have an issue? J. Clin. Orthop. Trauma 2024, 52, 102430. [Google Scholar] [CrossRef] [PubMed]
- Tan, T.L.; Kheir, M.M.; Shohat, N.; Tan, D.D.; Kheir, M.; Chen, C.; Parvizi, J. Culture-Negative Periprosthetic Joint Infection: An Update on What to Expect. JBJS Open Access 2018, 3, e0060. [Google Scholar] [CrossRef] [PubMed]
- Brivio, A.; Al-Jabri, T.; Martin, J.; Barrett, D.; Maffulli, N. Debridement, antibiotics and implant retention (DAIR) is successful in the management of acutely infected unicompartmental knee arthroplasty: A case series. Ann. Med. 2023, 55, 680–688. [Google Scholar] [CrossRef] [PubMed]
- Wignadasan, W.; Ibrahim, M.; Haddad, F.S. One- or two-stage reimplantation for infected total knee prosthesis? Orthop. Traumatol. Surg. Res. 2023, 109, 103453. [Google Scholar] [CrossRef]
- Kuiper, J.W.; Willink, R.T.; Moojen, D.J.; van den Bekerom, M.P.; Colen, S. Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts. World J. Orthop. 2014, 5, 667–676. [Google Scholar] [CrossRef]
- Zhu, M.F.; Kim, K.; Cavadino, A.; Coleman, B.; Munro, J.T.; Young, S.W. Success Rates of Debridement, Antibiotics, and Implant Retention in 230 Infected Total Knee Arthroplasties: Implications for Classification of Periprosthetic Joint Infection. J. Arthroplast. 2021, 36, 305–310.e1. [Google Scholar] [CrossRef]
- Parkinson, R.W.; Kay, P.R.; Rawal, A. A case for one-stage revision in infected total knee arthroplasty? Knee 2011, 18, 1–4. [Google Scholar] [CrossRef]
- Zhang, Y.; Gao, Z.; Zhang, T.; Dong, Y.; Sheng, Z.; Zhang, F.; Zhou, Y.; Guo, L. A comparsion study between debridement, antibiotics, and implant retention and two-stage revision total knee arthroplasty for the management of periprosthetic joint infection occurring within 12 weeks from index total knee arthroplasty. J. Orthop. Surg. Res. 2022, 17, 330. [Google Scholar] [CrossRef]
- Lazic, I.; Scheele, C.; Pohlig, F.; von Eisenhart-Rothe, R.; Suren, C. Treatment options in PJI—Is two-stage still gold standard? J. Orthop. 2021, 23, 180–184. [Google Scholar] [CrossRef]
- Del Arco, A.; Bertrand, M.L. The diagnosis of periprosthetic infection. Open Orthop. J. 2013, 7, 178–183. [Google Scholar] [CrossRef]
TKA (n = 71) | UKA (n = 11) | p-Value | |
---|---|---|---|
Age (years) | 67.7 ± 7.2 | 59.8 ± 7.0 | 0.004 a |
Gender | 0.520 b | ||
Female | 46 (64.8%) | 6 (54.5%) | |
Male | 25 (35.2%) | 5 (45.5%) | |
Operation side | 0.336 b | ||
Left | 39 (54.9%) | 3 (27.3%) | |
Right | 32 (45.1%) | 8 (72.7%) | |
Surgical Procedure | 0.002 b | ||
DAIR | 20 (28.2%) | 8 (72.7%) | |
Two-stage revision | 51 (71.8%) | 3 (27.3%) | |
Median Follow-up Time | 45 months | 49 months | 0.976 c |
(IQR) | (30–63) | (27–66) |
TKA (n = 71) | UKA (n = 11) | p-Value | |
---|---|---|---|
DAIR | 20 (28.2%) | 8 (72.7%) | 0.002 a |
No recurrence | 16 (80.0%) | 7 (87.5%) | |
Infection recurrence (required 2-stage revision) | 4 (20.0%) | 1 (12.5%) | |
Two-stage revision | 51 (71.8%) | 3 (27.3%) | 0.002 a |
No recurrence | 46 (90.2%) | 3 (100%) | |
Infection recurrence | 5 (9.8%) | 0 (0%) |
Microorganisms | TKA (n = 71) n (%) | UKA (n = 11) n (%) |
---|---|---|
Gram-positive microorganisms | ||
Staphylococcus aureus | 17 (25.3) | 6 (54.5) |
-MRSA | 9 (14.1) | 1 (9.1) |
Coagulase-negative staphylococci | 10 (14.1) | 3 (27.3) |
-MRCoNS | 9 (12.6) | 0 (0) |
Streptococcus spp. | 5 (7) | 0 (0) |
Enterococcus spp. | 3 (4.2) | 0 (0) |
Bacillus spp. | 1 (1.4) | 0 (0) |
Gram-negative microorganisms | ||
Enterobacteriaceae | ||
E. coli | 3 (4.2) | 0 (0) |
-ESBL producing | 2 (2.8) | 0 (0) |
Klebsiella spp. | 2 (2.8) | 0 (0) |
-ESBL producing | 1(1.4) | 0 (0) |
Serratia marcescens | 1 (1.4) | 0 (0) |
-ESBL producing | 1 (1.4) | 0 (0) |
Non-fermentative Gram-negative bacilli | ||
Pseudomonas aeruginosa | 2 (2.8) | 0 (0) |
Other | ||
Polymicrobial | 2 (2.8) | 0 (0) |
Culture Negative | 25 (33.8) | 2 (18.2) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nazlıgül, A.S.; Güven, Ş.; Erdoğan, Y.; Fırat, A.; Doğan, M.; Akkaya, M. Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes. Antibiotics 2025, 14, 585. https://doi.org/10.3390/antibiotics14060585
Nazlıgül AS, Güven Ş, Erdoğan Y, Fırat A, Doğan M, Akkaya M. Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes. Antibiotics. 2025; 14(6):585. https://doi.org/10.3390/antibiotics14060585
Chicago/Turabian StyleNazlıgül, Ali Said, Şahan Güven, Yasin Erdoğan, Ahmet Fırat, Metin Doğan, and Mustafa Akkaya. 2025. "Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes" Antibiotics 14, no. 6: 585. https://doi.org/10.3390/antibiotics14060585
APA StyleNazlıgül, A. S., Güven, Ş., Erdoğan, Y., Fırat, A., Doğan, M., & Akkaya, M. (2025). Periprosthetic Joint Infection in Unicompartmental vs. Total Knee Arthroplasty: Microbiological Spectrum and Management Outcomes. Antibiotics, 14(6), 585. https://doi.org/10.3390/antibiotics14060585